251 related articles for article (PubMed ID: 26992667)
21. Does the presence of placental basal plate myometrial fibres increase the risk of subsequent morbidly adherent placenta: a case-control study.
Miller ES; Linn RL; Ernst LM
BJOG; 2016 Dec; 123(13):2140-2145. PubMed ID: 26265563
[TBL] [Abstract][Full Text] [Related]
22. Characterization of placenta accreta using transvaginal sonography and color Doppler imaging.
Lerner JP; Deane S; Timor-Tritsch IE
Ultrasound Obstet Gynecol; 1995 Mar; 5(3):198-201. PubMed ID: 7788495
[TBL] [Abstract][Full Text] [Related]
23. Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa.
Wang N; Shi D; Li N; Qi H
Ann Med; 2021 Dec; 53(1):2041-2049. PubMed ID: 34927512
[TBL] [Abstract][Full Text] [Related]
24. Serum angiogenic profile in abnormal placentation.
Biberoglu E; Kirbas A; Daglar K; Biberoglu K; Timur H; Demirtas C; Karabulut E; Danisman N
J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3193-7. PubMed ID: 26863111
[TBL] [Abstract][Full Text] [Related]
25. Placenta previa-accreta: risk factors and complications.
Usta IM; Hobeika EM; Musa AA; Gabriel GE; Nassar AH
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1045-9. PubMed ID: 16157109
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of angiopoietin-1, angiopoietin-2, and Tie receptors in placentas from pregnancies complicated by placenta accreta.
Tseng JJ; Hsu SL; Ho ES; Hsieh YT; Wen MC; Chou MM
Am J Obstet Gynecol; 2006 Feb; 194(2):564-71. PubMed ID: 16458662
[TBL] [Abstract][Full Text] [Related]
27. Relationship between first trimester aneuploidy screening test serum analytes and placenta accreta.
Büke B; Akkaya H; Demir S; Sağol S; Şimşek D; Başol G; Barutçuoğlu B
J Matern Fetal Neonatal Med; 2018 Jan; 31(1):59-62. PubMed ID: 28027672
[TBL] [Abstract][Full Text] [Related]
28. Expression of β-catenin in human trophoblast and its role in placenta accreta and placenta previa.
Han Q; Zheng L; Liu Z; Luo J; Chen R; Yan J
J Int Med Res; 2019 Jan; 47(1):206-214. PubMed ID: 30465458
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis of Placenta Accreta by Uterine Artery Doppler Velocimetry in Patients With Placenta Previa.
Cho HY; Hwang HS; Jung I; Park YW; Kwon JY; Kim YH
J Ultrasound Med; 2015 Sep; 34(9):1571-5. PubMed ID: 26254156
[TBL] [Abstract][Full Text] [Related]
30. Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta.
El Behery MM; Rasha L E; El Alfy Y
Int J Gynaecol Obstet; 2010 Apr; 109(1):30-3. PubMed ID: 20070963
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for placenta accreta: a large prospective cohort.
Bowman ZS; Eller AG; Bardsley TR; Greene T; Varner MW; Silver RM
Am J Perinatol; 2014 Oct; 31(9):799-804. PubMed ID: 24338130
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of maternal serum VEGF, TNF-alpha, IL-4, and IL-10 levels in differentiating placenta accreta spectrum from isolated placenta previa.
Farisoğullari N; Tanaçan A; Sakcak B; Denizli R; Baştemur AG; Başaran E; Kara Ö; Yazihan N; Şahin D
Cytokine; 2024 Apr; 176():156513. PubMed ID: 38262117
[TBL] [Abstract][Full Text] [Related]
33. Extravillous trophoblast invasion in placenta accreta is associated with differential local expression of angiogenic and growth factors: a cross-sectional study.
Duzyj CM; Buhimschi IA; Laky CA; Cozzini G; Zhao G; Wehrum M; Buhimschi CS
BJOG; 2018 Oct; 125(11):1441-1448. PubMed ID: 29469945
[TBL] [Abstract][Full Text] [Related]
34. Placenta accreta. A clinicopathologic review of 67 cases.
Morison JE
Obstet Gynecol Annu; 1978; 7():107-23. PubMed ID: 662213
[TBL] [Abstract][Full Text] [Related]
35. Placenta previa/accreta and prior cesarean section.
Clark SL; Koonings PP; Phelan JP
Obstet Gynecol; 1985 Jul; 66(1):89-92. PubMed ID: 4011075
[TBL] [Abstract][Full Text] [Related]
36. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births.
Eshkoli T; Weintraub AY; Sergienko R; Sheiner E
Am J Obstet Gynecol; 2013 Mar; 208(3):219.e1-7. PubMed ID: 23313722
[TBL] [Abstract][Full Text] [Related]
37. Can venous ProBNP levels predict placenta accreta?
Ersoy AO; Oztas E; Ozler S; Ersoy E; Erkenekli K; Uygur D; Caglar AT; Danisman N
J Matern Fetal Neonatal Med; 2016 Dec; 29(24):4020-4. PubMed ID: 26864469
[TBL] [Abstract][Full Text] [Related]
38. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality.
Solheim KN; Esakoff TF; Little SE; Cheng YW; Sparks TN; Caughey AB
J Matern Fetal Neonatal Med; 2011 Nov; 24(11):1341-6. PubMed ID: 21381881
[TBL] [Abstract][Full Text] [Related]
39. Cesarean section and placental disorders in subsequent pregnancies--a meta-analysis.
Klar M; Michels KB
J Perinat Med; 2014 Sep; 42(5):571-83. PubMed ID: 24566357
[TBL] [Abstract][Full Text] [Related]
40. Association of maternal serum Netrin-1 and Netrin-4 levels with placenta accreta spectrum.
Kaya S; Turhan U; Dağ I; Polat I
Eur Rev Med Pharmacol Sci; 2023 May; 27(10):4594-4600. PubMed ID: 37259741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
